These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6755409)

  • 21. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
    Epstein JI; Eggleston JC
    Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate carcinoma with squamous differentiation: an analysis of 33 cases.
    Parwani AV; Kronz JD; Genega EM; Gaudin P; Chang S; Epstein JI
    Am J Surg Pathol; 2004 May; 28(5):651-7. PubMed ID: 15105655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An electron microscopic study of the human prostatic cancer: with special references to lysosomal system in prostatic cancer and to high dose estrogen effect upon prostatic cancer].
    Ishikawa F
    Nihon Hinyokika Gakkai Zasshi; 1971 Jun; 62(6):439-66. PubMed ID: 5104091
    [No Abstract]   [Full Text] [Related]  

  • 24. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.
    Gleason DF; Mellinger GT
    J Urol; 1974 Jan; 111(1):58-64. PubMed ID: 4813554
    [No Abstract]   [Full Text] [Related]  

  • 25. Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
    Broghamer WL; Richardson ME; Faurest S; Parker JE
    Acta Cytol; 1985; 29(3):274-8. PubMed ID: 3890441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of leuprolide and diethylstilbestrol for stage D2 adenocarcinoma of prostate.
    Sharifi R; Lee M; Ojeda L; Ray P; Stobnicki M; Guinan P
    Urology; 1985 Aug; 26(2):117-24. PubMed ID: 3927551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostatic involvement in bladder cancer. Prostate mapping in 20 cystoprostatectomy specimens.
    Mahadevia PS; Koss LG; Tar IJ
    Cancer; 1986 Nov; 58(9):2096-102. PubMed ID: 3530431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I trial of high-dose fosfestrol in hormone-refractory adenocarcinoma of the prostate.
    Droz JP; De Smedt E; Kattan J; Keuppens F; Khoury S; Mahler C; Denis L
    Prostate; 1994; 24(2):62-6. PubMed ID: 7508621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostatic acid phosphatase: its current clinical status.
    Heller JE
    J Urol; 1987 Jun; 137(6):1091-103. PubMed ID: 3295298
    [No Abstract]   [Full Text] [Related]  

  • 30. Carcinoma of the prostate and lymphatic metastases.
    McCullough DL; Prout GR; Daly JJ
    J Urol; 1974 Jan; 111(1):65-71. PubMed ID: 4813555
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunodiagnosis by prostatic acid phosphatase to differentiate primary male breast cancer from metastatic prostate cancer.
    Kumar PP; Good RR; Newland JR
    J Natl Med Assoc; 1986 Aug; 78(8):782-4, 786. PubMed ID: 3531533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate specific acid phosphatase: further studies with immunological techniques.
    Davies SN; Griffiths JC
    Clin Chim Acta; 1982 Jun; 122(1):29-38. PubMed ID: 6178538
    [No Abstract]   [Full Text] [Related]  

  • 33. Papillary adenocarcinomas of the prostate. An immunohistochemical study.
    Kuhajda FP; Gipson T; Mendelsohn G
    Cancer; 1984 Oct; 54(7):1328-32. PubMed ID: 6205741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orchiectomy for advanced prostatic carcinoma. A reevaluation.
    Blackard CE; Byar DP; Jordan WP
    Urology; 1973 Jun; 1(6):553-60. PubMed ID: 4588820
    [No Abstract]   [Full Text] [Related]  

  • 35. Enzyme immunoassay of prostatic acid phosphatase after prostatic examination. Correlation with prostate size and immunopathology.
    el-Shirbiny AM; Shridhar P; al Adnani MS; Suresh LK
    Urology; 1988 Nov; 32(5):469-73. PubMed ID: 2460989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of prostate carcinoma with bilateral orbital metastases and the review of the literature.
    Carriere VM; Karcioglu ZA; Apple DJ; Insler MS
    Ophthalmology; 1982 Apr; 89(4):402-6. PubMed ID: 7099558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases.
    Epstein JI; Woodruff JM
    Cancer; 1986 Jan; 57(1):111-9. PubMed ID: 2416422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transitional cell carcinoma of the prostate.
    Algaba F; Santaularia JM; Lamas M; Ayala G
    Eur Urol; 1985; 11(2):87-90. PubMed ID: 3891355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of total and prostatic fraction serum acid phosphatase levels in patients with differentiated and undifferentiated prostatic carcinoma.
    Murphy GP; Reynoso G; Kenny GM; Gaeta JF
    Cancer; 1969 Jun; 23(6):1309-14. PubMed ID: 4306102
    [No Abstract]   [Full Text] [Related]  

  • 40. [Detection of prostate specific acid phosphatase in paraffin sections].
    de Vries GP; Stegehuis F; Jöbsis AC; Meijer AE
    Acta Histochem Suppl; 1980; 21():33-8. PubMed ID: 6808565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.